Maha Radhakrishnan, MD

Dr. Maha Radhakrishnan recently served as group senior vice president and chief medical officer of Biogen, responsible for the worldwide medical function, until March 2024. Previously, Dr. Radhakrishnan was senior vice president and global head of the medical, primary care business unit at Sanofi, a global biopharmaceutical company focused on human health. At Sanofi, she led the medical function providing medical strategy for the diabetes and cardiovascular products and programs in development. Previously, she held several leadership roles at Bioverativ Inc., Bristol Myers Squibb, United Health Group, and Cephalon. Dr. Radhakrishnan has extensive experience across therapeutic areas in overseeing the external scientific engagement strategy and real-world data generation with academic institutions, top key opinion leaders, patient advocacy groups, payers, and regulators. She received her MD in internal medicine with honors from the People’s Friendship University in Moscow, Russia, in 1995, as well as a master’s degree in Russian language. Dr. Radhakrishnan is also a certified Russian language instructor and interpreter.